Related references
Note: Only part of the references are listed.Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Human Anti-Macrophage Migration Inhibitory Factor Antibodies Inhibit Growth of Human Prostate Cancer Cells In Vitro and In Vivo
Filza Hussain et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Tumor-derived macrophage migration inhibitory factor promotes an autocrine loop that enhances renal cell carcinoma
W. Du et al.
ONCOGENE (2013)
Hypoxia-Inducible Factors in Physiology and Medicine
Gregg L. Semenza
CELL (2012)
Cholesterol and the development of clear-cell renal carcinoma
Harry A. Drabkin et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Neutralization of Macrophage Migration Inhibitory Factor (MIF) by Fully Human Antibodies Correlates with Their Specificity for the β-Sheet Structure of MIF
Randolf J. Kerschbaumer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Negative Regulation of AMP-activated Protein Kinase (AMPK) Activity by Macrophage Migration Inhibitory Factor (MIF) Family Members in Non-small Cell Lung Carcinomas
Stephanie E. Brock et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Macrophage Migration Inhibitory Factor Promotes Tumor Growth and Metastasis by Inducing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Kendra D. Simpson et al.
JOURNAL OF IMMUNOLOGY (2012)
Novel agents in renal carcinoma: a reality check
Yana G. Najjar et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2012)
Role of Macrophage Migration Inhibitory Factor in Primary Glioblastoma Multiforme Cells
Nina Baron et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF)
Melanie Merk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Receptor agonists of macrophage migration inhibitory factor
William L. Jorgensen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Autocrine Induction of Invasive and Metastatic Phenotypes by the MIF-CXCR4 Axis in Drug-Resistant Human Colon Cancer Cells
Anne-Frederique Dessein et al.
CANCER RESEARCH (2010)
Sunitinib Acts Primarily on Tumor Endothelium rather than Tumor Cells to Inhibit the Growth of Renal Cell Carcinoma
Dan Huang et al.
CANCER RESEARCH (2010)
Regulation of the Histone Demethylase JMJD1A by Hypoxia-Inducible Factor 1 alpha Enhances Hypoxic Gene Expression and Tumor Growth
Adam J. Krieg et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
The MIF Homologue D-Dopachrome Tautomerase Promotes COX-2 Expression through β-Catenin-Dependent and -Independent Mechanisms
Dan Xin et al.
MOLECULAR CANCER RESEARCH (2010)
A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells
Millicent Winner et al.
CANCER RESEARCH (2008)
Turn me on: regulating HIF transcriptional activity
K. Lisy et al.
CELL DEATH AND DIFFERENTIATION (2008)
The role of hypoxia-inducible factors in tumorigenesis
E. B. Rankin et al.
CELL DEATH AND DIFFERENTIATION (2008)
Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase
Arlixer M. Coleman et al.
JOURNAL OF IMMUNOLOGY (2008)
Role of MIF in Inflammation and Tumorigenesis
Jan-Philipp Bach et al.
ONCOLOGY (2008)
The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer
William G. Kaelin
NATURE REVIEWS CANCER (2008)
Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity
H. Lue et al.
ONCOGENE (2007)
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment
Juergen Bernhagen et al.
NATURE MEDICINE (2007)
Hypoxia in cancer: significance and impact on clinical outcome
Peter Vaupel et al.
CANCER AND METASTASIS REVIEWS (2007)
HIF1α delays premature senescence through the activation of MIF
Scott M. Welford et al.
GENES & DEVELOPMENT (2006)
Role of hypoxia-inducible factor-1α as a cancer therapy target
Shalini Patiar et al.
ENDOCRINE-RELATED CANCER (2006)
CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex
Xuerong Shi et al.
IMMUNITY (2006)
Dual regulation of macrophage migration inhibitory factor (MIF) expression in hypoxia by CREB and HIF-1
John A. Baugh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Role of hypoxia-inducible factor (HIF)-1α-versus HIF-2α in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-1, or loss of von Hippel-Lindau function:: Implications for targeting the HIF pathway
Veronica A. Carroll et al.
CANCER RESEARCH (2006)
ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis
Y Al-Abed et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells
KL Meyer-Siegler et al.
BMC CANCER (2004)
The cytokine macrophage migration inhibitory factor reduces pro-oxidative stress-induced apoptosis
MT Nguyen et al.
JOURNAL OF IMMUNOLOGY (2003)
HIF activation identifies early lesions in VHL kidneys: Evidence for site-specific tumor suppressor function in the nephron
SJ Mandriota et al.
CANCER CELL (2002)
Share Paper
